EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 2, 2016

Study Completion Date

December 2, 2016

Conditions
Type 1 Diabetes
Interventions
DRUG

Metformin

DRUG

Placebo

Trial Locations (1)

80045

Children's Hospital Colorado and University of Colorado Denver Health Sciences Center, Aurora

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Colorado, Denver

OTHER

NCT01808690 - EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes | Biotech Hunter | Biotech Hunter